Investment analysts at StockNews.com started coverage on shares of Oxbridge Re (NASDAQ:OXBR – Get Rating) in a report issued on Wednesday. The brokerage set a “hold” rating on the insurance provider’s stock.
Separately, TheStreet downgraded shares of Oxbridge Re from a “b-” rating to a “c+” rating in a research report on Friday, July 8th.
Oxbridge Re Stock Performance
Shares of Oxbridge Re stock opened at $2.39 on Wednesday. Oxbridge Re has a 1 year low of $2.36 and a 1 year high of $7.13. The firm’s 50-day simple moving average is $3.03 and its 200-day simple moving average is $4.25. The firm has a market cap of $13.82 million, a PE ratio of 1.77 and a beta of 0.99.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Oxbridge Re stock. Dorsey Wright & Associates acquired a new stake in Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Rating) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 7,400 shares of the insurance provider’s stock, valued at approximately $41,000. Dorsey Wright & Associates owned approximately 0.13% of Oxbridge Re at the end of the most recent reporting period. Hedge funds and other institutional investors own 21.68% of the company’s stock.
Oxbridge Re Company Profile
Oxbridge Re Holdings Limited, together with its subsidiaries, provides specialty property and casualty reinsurance solutions. It underwrites reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. The company distributes its products and solutions through reinsurance brokers.
- Get a free copy of the StockNews.com research report on Oxbridge Re (OXBR)
- 3 Airline Stocks Stuck in a Holding Pattern
- Roku Stock is Down but Not Out
- Is Ford Rolling To A Rebound After Its Q3 Warning
- If You’re Hungry for Value, Take a Bite on Ruth’s Hospitality Grp
- Has AMD stock stock fallen too far?
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.